CERTIFICATIONS AND LICENSURES
- 2014 Diplomat, Thai Board of Medical Oncology
- 2011 Certificate of Postgraduate Clinical Medical Sciences, Mahidol University, Thailand
- 2010 Certificate of Medical Licensure, Thailand
AWARDS AND HONORS
- 2014 International Development and Education Award from Conquer Cancer Foundation of the American Society of Clinical Oncology
- 2003 PhD scholarship from The Head and Neck Cancer Research Trust, UK
- 2001 Medical scholars program, Mahidol University
- 2000 Scholarship award for highest score in Clinical Pathology, Faculty of Medicine Siriraj Hospital
PROFESSIONAL SOCIETY MEMBERSHIP
- 2014 Member of the Thai Society of Clinical Oncology.
- 2013 Member of the Royal College of Physicians of Thailand.
- 2010 Member of the Medical Council of Thailand.
PUBLICATIONS, PRESENTATION AND RESEARCHES
1. Luangdilok, S., Box, C., Patterson, L., Court, W., Harrington, K., Pitkin, L., Rhys-Evans, P., P, O.c., and Eccles, S. (2007). Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer Res 67, 7907-7916.
2. Pitkin, L., Luangdilok, S., Corbishley, C., Wilson, P.O., Dalton, P., Bray, D., Mady, S., Williamson, P., Odutoye, T., Rhys Evans, P., et al. (2007). Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival. Br J Cancer 97, 670-677.
3. Luangdilok, S., Box, C., Harrington, K., Rhys-Evans, P., and Eccles, S. (2011). MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. Eur J Cancer 47, 520-529.
4. Luangdilok, S., Samarnthai, N., and Korphaisarn, K. (2014). Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients. J Breast Cancer 17, 376-385.
5. Sutepvarnon A, Sriburom K, Chochai P, Luangdilok S. Rare paraneoplastic aplastic anemia in malignant thymoma patient: a case report, Vajira Med J 2015; 59(4): 59-64
6. Wanchaijiraboon, P., Sriuranpong, V., Luangdilok, S., and Chantranuwat, P. (2018). Characteristics of K-ras mutation lung cancer in an East Asian institute. Journal of Clinical Oncology 36, e21206-e21206.
7. Vimolchalao, V., Sakdejayont, S., Wongchanapai, P., Sukprakun, S., Uttamapinan, S., Sintawichai, N., Poovorawan, N., Luangdilok, S., Parinyanitikul, N., Vinayanuwattikun, C., et al. (2018). Efficacy and safety of additional olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting: A randomized, double-blind, placebo-controlled, crossover study. Journal of Clinical Oncology 36, 10019-10019.
8. Tanasanvimon, S., Ungtrakul, T., Poovorawan, N., Parinyanitikul, N., Vinayanuwattikun, C., Mingmalairak, S., Luangdilok, S., Lamlertthon, W., and Sriuranpong, V. (2018). A phase 2 study of s-1 plus leucovorin in patients with untreated advanced cholangiocarcinoma (CCA). Journal of Clinical Oncology 36, 467-467.
9. Luangdilok S, Wanchaijiraboon P, Poonchavist Chantranuwatana, Chinachote Teerapakpinyo, Shanop Shuangshoti, Virote Sriuranpong (2019) Cyclin D1 expression as a potential prognostic factor in advanced KRAS-mutant non-small cell lung cancer. Translational Lung Cancer Research 8 (6), 959–966.
Book Chapters
10. สุทิมา เหลืองดิลก ชีววิทยาของมะเร็งปอด ใน วิโรจน์ ศรีอุฬารพงศ์, บรรณาธิการ มะเร็งปอด (LUNG CANCER), e-book ศูนย์หนังสือแห่งจุฬาลงกรณ์มหาวิทยาลัย พ.ศ. 2561 หน้า 1-11
Reviewer
- Journal of Clinical Oncology in 2016